HIGHLIGHTS
- who: Chronic Heart Failure et al. from the Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China, Department of Cardiology Center, Hebei have published the paper: Dapagli fl ozin Attenuates Myocardial Fibrosis by Inhibiting the TGF- u03b2 1/ Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure, in the Journal: (JOURNAL) of 10/02/2022
- what: The authors aimed to investigate the cardioprotective effect of SGLT2 inhibitors in a normoglycemic rabbit model of_(CHF) and its potential mechanism was also explored. The authors assessed the efficacy of the SGLT2 inhibitor dapagliflozin (DAPA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.